Motor Control Plus Isolated Lumbar Extension
Cross-source consensus on Motor Control Plus Isolated Lumbar Extension from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Dosage & preparation
Preparation
Highlighted claims
- The experimental intervention combines motor control exercise with isolated lumbar extension training. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers
- Isolated lumbar extension is added to stimulate and activate the lumbar extensors. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers
- The protocol increases ILEX resistance if the participant completes target repetitions before failure. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers
- Motor control exercise is based on impaired trunk muscle control and coordination in people with low back pain. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers
- The motor control programme is individualised to each participant’s impairments and goals. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers
- Participants train deep trunk muscle contraction while limiting overactivity of superficial global muscles. — Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers